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Introduction 
Changes in the biological characteristics of HIV-l 
from peripheral blood leucocytes (PBL) have been 
well documented. It has been suggested that changes 
with time in the biological features of HIV are signs 
of increased virulence. Attempts have been made to 
link replication potential and the cytopathic syncytia- 
inducing properties of HIV isolates with the clinical 
status and severity of HIV infection in the host. 
Despite the fact that HIV has been isolated from the 
lung, little is known about the properties of these 
isolates in contrast to isolates derived from PBL. We 
report the changing nature of HIV infection in the 
lung in a patient following the successful treatment of 
Pneumocystis carinii pneumonia (PCP). Pulmonary 
HIV infection, but not HIV isolated from PBL, 
evolved to become syncytium-inducing within 3 
months. This may have important implications 
regarding the pathogenesis of HIV disease. 
Report 
HIV-l strains vary remarkably in their cellular 
tropism and a multitude of phenotypic variants exist 
(1). The replication capacity of HIV falls into two 
broad designations, viruses that grow rapidly to high 
titre (‘rapid/high’) and those that replicate slowly 
with only small amounts of virus recoverable (‘slow/ 
low’). It has been suggested that the progression to 
AIDS in infected individuals correlates with the 
emergence of ‘rapid/high’ HIV variants, resulting in 
decreased CD4 cell counts (1,2) and that changes in 
the biological features of HIV in vitro with time are 
signs of increased virulence of HIV to the host. 
HIV has been detected in the lungs of AIDS 
patients (3) by a number of methods including the 
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detection of reverse transcriptase (3), P24 antigens (3) 
and HIV proviral DNA (3) in alveolar macrophages. 
In addition, viral RNA transcripts have been found 
in lung tissue from AIDS patients with pulmonary 
infection (4) and HIV has been isolated from bron- 
choalveolar lavage (BAL) from individuals with 
pulmonary disease (3). However, despite the fact that 
HIV has been isolated from the lung, little is known 
about the biological or molecular properties of these 
isolates in contrast to isolates derived from PBL. 
We report rapid changes in HIV isolates obtained 
from the lung sequentially from a single patient. A 
27-year-old male presented with 2 months of weight 
loss of 1.5 stone, shortness of breath and a dry cough. 
His HIV status was confirmed at the time of 
bronchoscopy. Chest X-ray showed changes typical 
of PCP and this was confirmed cytologically at 
bronchoscopy. He received a 3-week course of 
co-trimoxazole (20 mg kg - ’ day - ’ trimethoprim; 
lOOmgkg-‘day-’ sulphamethoxazole) but he 
remained unwell with fever. A second bronchoscopy 
was done 2 weeks later to exclude a second pathogen. 
All cultures were negative but the patient responded 
to a combination of erythromycin and ciprofloxacin. 
Two months later, he complained of a 2-week history 
of increasing shortness of breath with cough produc- 
tive of mucoid sputum. He was febrile and wide- 
spread crackles were audible. The chest X-ray on this 
occasion was normal but the carbon monoxide trans- 
fer factor (TLCO) was reduced to 51% of predicted 
normal, indicating the presence of a pulmonary 
abnormality. A third bronchoscopy was undertaken 
but no specific pathogen was detected in the BAL, 
and transbronchial lung biopsies showed normal lung 
tissue only (Table 1). He responded to broad spec- 
trum antibiotics, although his respiratory crackles 
persisted. 
The patient subsequently developed both CMV 
retinitis and colitis which were treated successfully 
with ganciclovir (Table 2). He continued to suffer 
from dyspnoea, occasional fevers and audible 
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Table I Laboratory investigation on peripheral blood and bronchoalveolar lavage cells 
Number of Number of 
Date of Viral isolation DNA copies/ host cells infected/ 
bronchoscopy Sample (days to detection) Syncytia 10h cells lo6 cells 
26.6.91 
10.7.91 
26.9.91 
10.2.93 
PBL 9 
BAL 16 
PBL 2 
BAL 2 
PBL 5 
BAL 18h 
PBL 1 
BAL 1 
++ 
++ 
++ 
100 nd 
100 nd 
1000 nd 
1000 nd 
1000 100 
10 000 10 000 
1500 na 
8000 na 
PBL, peripheral blood lymphocyte; BAL, bronchoalveolar lavage; nd, not done; na, not 
available; - , syncytia absent; + +, syncytia present. 
Table 2 Clinical course 
Date of diagnosis Diagnosis 
26.6.91 PCP (AIDS-defining diagnosis) 
20.8.92 CMV retinitis and colitis 
21.3.93 Pseudomonas chest infection 
10.9.94 MA1 isolated from sputum 
20.1.94 AIDS dementia complex 
25.5.94 Died 
PCP, Pneumocystis car&ii pneumonia; CMV, Cytomega- 
lovirus; MAI, Mycobacterium avium intracellulare. 
crackles throughout both lung fields and underwent a 
further bronchoscopy in February 1993 but, again, 
no specific pathogen was detected. Both Pseudomo- 
nas spp. and Mycobacterium avium intracellulare 
were isolated from sputum 2 years after his initial 
AIDS diagnosis. He subsequently developed AIDS 
dementia complex associated with cerebral atrophy 
in January 1994 and died in May 1994. 
At each bronchoscopy, peripheral blood and BAL 
were investigated. An aliquot of 1 x lo6 cells of PBL 
and BAL cells were taken and DNA extracted using 
a standard technique. The DNA was investigated by 
the quantitative polymerase chain reaction (PCR) 
technique, to determine the amount of HIV proviral 
DNA present. From the last bronchoscopy, the 
cellular tropism of HIV isolates was determined in 
BAL and PBL. 
Virus isolation was carried out on all four paired 
PBL and BAL samples in the following way: 2 x lo6 
of either PBL or BAL cells were stimulated with 
1 pg ml- ’ of phytohaemagglutinin (PHA) and 100 
units ml ~ ’ of interleukin-2 (IL-2), and then 
co-cultivated with 1 x lo6 cord blood leucocytes 
(CBL) that had been stimulated for 3 days with 
1 pug ml - ’ PHA prior to use. The results of the 
laboratory investigations are shown in Table 1. In the 
first and second matched PBL and BAL samples, no 
viral induced syncytial cytopathic effect was visible 
by microscopic examination of the co-cultivation 
cultures. P24 antigen was detected in the PBL and 
BAL cell culture supernatants from the ninth and 
sixteenth day of culture respectively. P24 antigen was 
also detected in the PBL and BAL cultures of the 
second matched pair at 2 days in both samples. In the 
third matched PBL and BAL samples, P24 antigen 
was detectable in the supernatant from the BAL 
culture after 18 h. Large syncytia were also visible 
microscopically in the BAL cell culture at 2 days and 
developed to engulf most of the culture by 6 days 
post-infection. P24 antigen was detected in culture 
supernatant of both the fourth PBL and BAL 
matched samples by 24 h post-infection. In both 
instances, this was accompanied by pronounced syn- 
cytia which were observed in both cultures by 2 days 
post-infection. 
Polymerase chain reaction analysis of the PBL and 
BAL cells from this patient was undertaken using 
quantitative methodology (5). In the initial PBL and 
BAL samples, about 100 copies of HIV proviral 
DNA were detected/lo6 cells. In the second matched 
sample, taken 2 weeks after the first, a IO-fold 
increase in the amount of recoverable HIV proviral 
DNA was detectable in both samples. However, in 
the third pair of matched PBL and BAL samples, 
taken 10 weeks later, the number of HIV proviral 
DNA copies detected in lo6 PBL cells was 1000 
but had risen to 10 000 copies detectable from lo6 
BAL cells. A limiting cell dilution quantitative PCR 
analysis was also undertaken on the third matched 
PBL and BAL sample, in which a series of IO-fold 
Pulmonary HIV-l infection and PCP 375 
dilutions of PBL and BAL cells was also made 
for PCR examination to determine the number of 
cells in which HIV was detectable. Interestingly, the 
number of cells where HIV was detected by PCR 
from the PBL was 100, or 1: 10 000 cells, whilst HIV 
proviral DNA was detected in 10 000 BAL, or 1: 100 
cells. 
Viral tropism of HIV isolates from BAL and PBL 
at the time of the fourth bronchoscopy differed. In 
both these cell lines, isolates from BAL grew in 
CEM, H9, and MOLT-4 lymphoblastoid cell lines 
and HL-60, and U937 monoblastoid cell lines in 
addition to CBL primary cells producing syncytia in 
all cell lines, whereas the matched PBL showed 
restricted tropism and grew in CEM lymphoblastoid 
cells and CBL only but did produce syncytia. Bron- 
choalveolar lavage and PBL strains could not be 
distinguished by replication kinetics in CBL. In this 
respect, we have used CBL as a readily available 
source of peripheral blood mononuclear cells 
(PBMC). Most studies describing the cytopathic 
properties of HIV-l strains have relied upon growth 
of virus in continuous cell lines such as MT-2 (1). 
Most non-syncytium-inducing (NSI) strains of HIV-l 
do not, however, grow in MT-2 cells. It is well 
established that the growth of many clinical isolates 
of HIV-l is highly restricted to PBMC which are 
considered to be susceptible target cells for all vari- 
ants of HIV-l (6). Indeed, HIV-l is not only capable 
of growth in PBMC but many strains can also cause 
syncytium formation. 
We have previously shown that the biological 
phenotype of HIV-l isolated from the lung of AIDS 
patients can be distinguished in all instances from the 
corresponding strain isolated simultaneously from 
the peripheral blood (7). Indeed, others have found 
genotypic variation in the third (V3) and fourth (V4) 
hypervariable regions of the envelope gene of HIV 
strains obtained simultaneously from peripheral 
blood monocytes and alveolar macrophages (8). The 
extent of genetic variation within the V4 region was 
particularly striking and strongly suggests HIV may 
be evolving separately in the lung compared to in the 
peripheral blood. 
Biological and genetic heterogeneity of HIV-l iso- 
lates derived from PBL have been extensively studied 
(1,2). HIV-l strains exhibit differences in nucleotide 
sequences, neutralization by panels of antibodies, cell 
tropism and cytopathic effects (9, review). Even 
though HIV-l has been isolated from the lung of 
AIDS patients, little is known about the biological or 
molecular properties of these isolates. This is surpris- 
ing as opportunistic infections of the lung are impor- 
tant causes of morbidity and mortality in AIDS 
patients, and the diagnosis of PCP in HIV-l infected 
individuals is one of the most common AIDS 
defining diagnoses. 
Previously, we have shown that an episode of PCP 
does not predispose to HIV-l infection of BAL lung 
macrophages or lymphocytes nor, conversely, does 
HIV-l infection of these lung cells predispose indi- 
viduals to PCP (10). We have also shown previously 
that HIV-l can be detected by PCR in the BAL cells 
of 65% of AIDS patients (11). This report shows that 
HIV infection of the lung may change rapidly during 
PCP following successful treatment. From molecular 
studies of HIV, it is known that cellular factors 
stimulate the transcription of HIV RNA and upregu- 
late the production of HIV progeny. Therefore, it is 
tempting to speculate that the changes observed in 
the lung of this patient were due to the stimulation of 
virus infected cells by the opportunist pathogen. 
However, virus from the first BAL sample when PCP 
was present took 16 days to detect and was non- 
syncytiotropic, yet virus from the third BAL was 
isolated in 18 h and was highly syncytiotropic. At this 
stage, the patient had recovered fully from PCP 
(negative bronchoscopy) yet had persistent respir- 
atory symptoms of cough and breathlessness and 
abnormal lung function tests. Lung function follow- 
ing an episode of PCP may remain abnormal despite 
resolution of the pneumonia. The role of HIV per se 
in the development of this patient’s persistent respir- 
atory symptoms and abnormal lung function is 
unclear but raises interesting questions. 
Of further interest is the comparison between the 
PBL and BAL virus from this patient. In the first 
sample, virus was detectable by P24 antigen assay in 
the PBL by 9 days and the BAL at 16 days. In the 
second sample, virus was detectable in both samples 
by 2 days post-co-cultivation, whilst in the third 
BAL sample, virus was syncytia forming and 
could be detected overnight. This may be due to 
differences in the number of infected alveolar cells 
with replicating HIV recovered by bronchoscopy. 
However, quantitative PCR analysis and changes 
from non-cytopathic to syncytia-inducing virus 
indicates a rapidly evolving virus infection of the 
lung, possibly as a consequence of opportunist 
pneumonia. What is of particular interest is that high 
yield syncytia-inducing virus emerged from the lung 
in the third bronchoscopy sample and could possibly 
be a source of further infection of HIV to PBL 
trafficking through the lung. Finally, the tropism of 
viruses obtained from PBL and BAL at the fourth 
bronchoscopy differed, with the BAL virus isolate 
showing a greater range of tropism than the PBL 
virus. 
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